Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L van Riel

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
Bailliere'S Clinical Rheumatology|February 1, 1997
Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs)A M van Gestel, C J Haagsma, D E Furst, et al.
Annals of the Rheumatic Diseases|November 1, 1989
Disease assessment in rheumatoid arthritisP L Van Riel, D M Van der Heijde, L B Van de Putte
Scandinavian Journal of Rheumatology|January 1, 1990
Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazineD M van der Heijde, P L van Riel, L B van de Putte
British Journal of Rheumatology|November 1, 1993
Chronic polyarthritis due to Pseudomonas aeruginosaH A Van Heereveld, P L Van Riel, J F Meis, et al.
Clinical Rheumatology|March 1, 1984
Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind studyP L van Riel, L B van de Putte, F W Gribnau, et al.
The Journal of Rheumatology|April 1, 1983
Loose stools during auranofin treatment: clinical study and some pathogenetic possibilitiesP L van Riel, F W Gribnau, L B van de Putte, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 1990
[Risk factors for the development of side effects during treatment of rheumatoid arthritis with second-line antirheumatic agents; a review of the literature]M J Wijnands, P L van Riel, F W Gribnau, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Generalized urticarial eruption during azathioprine treatment for rheumatoid arthritis. A case report and review of the literatureM J Wijnands, C M Perret, P L van Riel, et al.
Seminars in Arthritis and Rheumatism|June 1, 1990
Risk factors of second-line antirheumatic drugs in rheumatoid arthritisM J Wijnands, P L van Riel, F W Gribnau, et al.
Scandinavian Journal of Rheumatology|January 1, 1995
Pseudoporphyria due to naproxen. A cluster of 3 casesM C Creemers, A Chang, M J Franssen, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Bailliere'S Clinical Rheumatology|February 1, 1997
Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs)A M van Gestel, C J Haagsma, D E Furst, et al.
Annals of the Rheumatic Diseases|November 1, 1989
Disease assessment in rheumatoid arthritisP L Van Riel, D M Van der Heijde, L B Van de Putte
Scandinavian Journal of Rheumatology|January 1, 1990
Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazineD M van der Heijde, P L van Riel, L B van de Putte
British Journal of Rheumatology|November 1, 1993
Chronic polyarthritis due to Pseudomonas aeruginosaH A Van Heereveld, P L Van Riel, J F Meis, et al.
Clinical Rheumatology|March 1, 1984
Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind studyP L van Riel, L B van de Putte, F W Gribnau, et al.
The Journal of Rheumatology|April 1, 1983
Loose stools during auranofin treatment: clinical study and some pathogenetic possibilitiesP L van Riel, F W Gribnau, L B van de Putte, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 21, 1990
[Risk factors for the development of side effects during treatment of rheumatoid arthritis with second-line antirheumatic agents; a review of the literature]M J Wijnands, P L van Riel, F W Gribnau, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Generalized urticarial eruption during azathioprine treatment for rheumatoid arthritis. A case report and review of the literatureM J Wijnands, C M Perret, P L van Riel, et al.
Seminars in Arthritis and Rheumatism|June 1, 1990
Risk factors of second-line antirheumatic drugs in rheumatoid arthritisM J Wijnands, P L van Riel, F W Gribnau, et al.
Scandinavian Journal of Rheumatology|January 1, 1995
Pseudoporphyria due to naproxen. A cluster of 3 casesM C Creemers, A Chang, M J Franssen, et al.
Pageof 15